Carcinoma, Intraductal, Noninfiltrating

"Carcinoma, Intraductal, Noninfiltrating" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

A noninvasive (noninfiltrating) carcinoma of the breast characterized by a proliferation of malignant epithelial cells confined to the mammary ducts or lobules, without light-microscopy evidence of invasion through the basement membrane into the surrounding stroma.

Descriptor ID	D002285
MeSH Number(s)	C04.557.470.200.025.275 C04.557.470.200.240.187.250 C04.557.470.615.275
Concept/Terms	Carcinoma, Intraductal, Noninfiltrating Carcinoma, Intraductal, Noninfiltrating Carcinoma, Intraductal Carcinomas, Intraductal Intraductal Carcinoma Intraductal Carcinomas DCIS Ductal Carcinoma In Situ Intraductal Carcinoma, Noninfiltrating Carcinoma, Noninfiltrating Intraductal Carcinomas, Noninfiltrating Intraductal Intraductal Carcinomas, Noninfiltrating Noninfiltrating Intraductal Carcinoma Noninfiltrating Intraductal Carcinomas Atypical Ductal Hyperplasia Atypical Ductal Hyperplasia Atypical Ductal Hyperplasias Ductal Hyperplasia, Atypical Ductal Hyperplasias, Atypical Hyperplasia, Atypical Ductal Hyperplasias, Atypical Ductal

Below are MeSH descriptors whose meaning is more general than "Carcinoma, Intraductal, Noninfiltrating".

Diseases [C]
Neoplasms [C04]
Neoplasms by Histologic Type [C04.557]
Neoplasms, Glandular and Epithelial [C04.557.470]
Carcinoma [C04.557.470.200]
Adenocarcinoma [C04.557.470.200.025]
Carcinoma, Intraductal, Noninfiltrating [C04.557.470.200.025.275]
Carcinoma in Situ [C04.557.470.200.240]
Breast Carcinoma In Situ [C04.557.470.200.240.187]
Carcinoma, Intraductal, Noninfiltrating [C04.557.470.200.240.187.250]
Neoplasms, Ductal, Lobular, and Medullary [C04.557.470.615]
Carcinoma, Intraductal, Noninfiltrating [C04.557.470.615.275]

Below are MeSH descriptors whose meaning is related to "Carcinoma, Intraductal, Noninfiltrating".

Below are MeSH descriptors whose meaning is more specific than "Carcinoma, Intraductal, Noninfiltrating".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Carcinoma, Intraductal, Noninfiltrating" by people in this website by year, and whether "Carcinoma, Intraductal, Noninfiltrating" was a major or minor topic of these publications.

Bar chart showing 22 publications over 17 distinct years, with a maximum of 3 publications in 2017

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
1993	0	1	1
2002	1	0	1
2003	1	0	1
2005	1	0	1
2006	1	0	1
2007	0	1	1
2011	1	0	1
2012	1	1	2
2013	1	0	1
2014	1	0	1
2015	1	0	1
2016	1	0	1
2017	3	0	3
2018	2	0	2
2019	1	1	2
2020	1	0	1
2022	1	0	1

Below are the most recent publications written about "Carcinoma, Intraductal, Noninfiltrating" by people in Profiles.

Casaubon J, Niakan S, Vicks E, Perez Coulter A, Jacobbe DL, Mason H. The effect of delay of excisional biopsy on upstage rate for atypical ductal hyperplasia, flat epithelial atypia, intraductal papilloma, and radial scar. Breast Cancer Res Treat. 2022 Dec; 196(3):527-534.

View in: PubMed
Zong Y, Montironi R, Massari F, Jiang Z, Lopez-Beltran A, Wheeler TM, Scarpelli M, Santoni M, Cimadamore A, Cheng L. Intraductal Carcinoma of the Prostate: Pathogenesis and Molecular Perspectives. Eur Urol Focus. 2021 09; 7(5):955-963.

View in: PubMed
Dialani V, Tseng I, Slanetz PJ, Fein-Zachary V, Phillips J, Karimova E, Brook A, Mehta TS. Potential role of abbreviated MRI for breast cancer screening in an academic medical center. Breast J. 2019 07; 25(4):604-611.

View in: PubMed
LaFemina J. Invited Commentary. J Am Coll Surg. 2019 06; 228(6):939-940.

View in: PubMed
Sprague BL, Vacek PM, Herschorn SD, James TA, Geller BM, Trentham-Dietz A, Stein JL, Weaver DL. Time-varying risks of second events following a DCIS diagnosis in the population-based Vermont DCIS cohort. Breast Cancer Res Treat. 2019 Feb; 174(1):227-235.

View in: PubMed
Amornsiripanitch N, Lam DL, Rahbar H. Advances in Breast MRI in the Setting of Ductal Carcinoma In Situ. Semin Roentgenol. 2018 Oct; 53(4):261-269.

View in: PubMed
Bremer T, Whitworth PW, Patel R, Savala J, Barry T, Lyle S, Leesman G, Linke SP, Jirstr?m K, Zhou W, Amini RM, W?rnberg F. A Biological Signature for Breast Ductal Carcinoma In Situ to Predict Radiotherapy Benefit and Assess Recurrence Risk. Clin Cancer Res. 2018 12 01; 24(23):5895-5901.

View in: PubMed
Montironi R, Cimadamore A, Gasparrini S, Mazzucchelli R, Santoni M, Massari F, Cheng L, Lopez-Beltran A, Scarpelli M. Prostate cancer with cribriform morphology: diagnosis, aggressiveness, molecular pathology and possible relationships with intraductal carcinoma. Expert Rev Anticancer Ther. 2018 07; 18(7):685-693.

View in: PubMed
Linsk A, Mehta TS, Dialani V, Brook A, Chadashvili T, Houlihan MJ, Sharma R. Surgical upgrade rate of breast atypia to malignancy: An academic center's experience and validation of a predictive model. Breast J. 2018 03; 24(2):115-119.

View in: PubMed
Gasparrini S, Cimadamore A, Mazzucchelli R, Scarpelli M, Massari F, Raspollini MR, Galosi AB, Lopez-Beltran A, Cheng L, Montironi R. Pathology and molecular updates in tumors of the prostate: towards a personalized approach. Expert Rev Mol Diagn. 2017 08; 17(8):781-789.

View in: PubMed

People

Explore

Similar Concepts

Top Journals